Gaurav Sharma

Dr. Gaurav Sharma

Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RTRavi Kumar Thakur
Ravi Kumar Thakur
PJPrince Joshi
Prince Joshi
PBPragati Baranwal
Pragati Baranwal
GSGaurav Sharma
Gaurav Sharma
SSSanjeev K. Shukla
Sanjeev K. Shukla
RTRama Pati Tripathi
Rama Pati Tripathi

1 January 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RTRavi Kumar Thakur
Ravi Kumar Thakur
PJPrince Joshi
Prince Joshi
KUKapil Upadhyaya
Kapil Upadhyaya
KSKartikey Singh
Kartikey Singh
GSGaurav Sharma
Gaurav Sharma
RTRama Pati Tripathi
Rama Pati Tripathi

22 June 2022 in Phytochemistry
Verified
Journal Article
Closed access
APAlka Raj Pandey
Alka Raj Pandey
SAShadab Ahmad
Shadab Ahmad
SSSuriya Pratap Singh
Suriya Pratap Singh
AMAnjali Mishra
Anjali Mishra
ABAmol Chhatrapati Bisen
Amol Chhatrapati Bisen
KSKoneni V. Sashidhara
Koneni V. Sashidhara

28 March 2025 in Science Advances
Verified
Journal Article
Open access
MCMario C. Chang
Mario C. Chang
VMVinay R. Malut
Vinay R. Malut
ROHIT MAHARROHIT MAHAR
ROHIT MAHAR
ARAnna Rushin
Anna Rushin
MMMarc A. McLeod
Marc A. McLeod
MMMatthew E. Merritt
Matthew E. Merritt
Metabolic imaging produces powerful visual assessments of organ function in vivo. Current techniques can be improved by safely increasing metabolic contrast. The gold standard, 2-[ 18 F]fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging, is limited by radioactive exposure and sparse assessment of metabolism beyond glucose uptake and retention. Deuterium magnetic resonance imaging (DMRI) with [6,6- 2 H 2 ]glucose is nonradioactive, achieves tumor metabolic contrast, but can be improved by enriched contrast from deuterated water (HDO) based imaging. Here, we developed a DMRI protocol employing [ 2 H 7 ]glucose. Imaging 2 H-signal and measuring HDO production in tumor-bearing mice detected differential glucose utilization across baseline tumors, tumors treated with vehicle control or anti-glycolytic BRAFi and MEKi therapy, and contralateral healthy tissue. Control tumors generated the most 2 H-signal and HDO. To our knowledge this is the first application of DMRI with [ 2 H 7 ]glucose for tumoral treatment monitoring. This approach demonstrates HDO as a marker of tumor glucose utilization and suggests translational capability in humans due to its safety, noninvasiveness, and suitability for serial monitoring.

20 November 2018 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
KSKartikey Singh
Kartikey Singh
GSGaurav Sharma
Gaurav Sharma
MSManjulika Shukla
Manjulika Shukla
RKRuchir Kant
Ruchir Kant
SCSidharth Chopra
Sidharth Chopra
RTRama Pati Tripathi
Rama Pati Tripathi

19 April 2021 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
LDLalita Devi
Lalita Devi
GSGaurav Sharma
Gaurav Sharma
RKRuchir Kant
Ruchir Kant
SSSanjeev K. Shukla
Sanjeev K. Shukla
NRNAMRATA RASTOGI
NAMRATA RASTOGI
A base-mediated reaction of triaryl/alkyl pyrylium tetrafluoroborate salts with α-diazo-phosphonates, sulfones and trifluoromethyl compounds affords the corresponding functionalized pyrazole-chalcones as 5-P-5 and 3-P-3 tautomeric mixture.